Last Updated: September 25, 2026

Details for Patent: 9,789,057

Name: Drug Patent Intelligence for US Patent 9789057
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,789,057 protect, and when does it expire?

Patent 9,789,057 protects CLINDESSE and is included in one NDA.

This patent has twenty-two patent family members in fourteen countries.

Summary for Patent: 9,789,057

Title:	Pharmaceutical delivery system
Abstract:	A pharmaceutical formulation to treat vaginal conditions in a human patient comprises:
Inventor(s):	Thomas C. Riley, R. Saul Levinson, Robert C. Cuca, Elio Mariani
Assignee:	Perrigo Co , Padagis US LLC
Application Number:	US13/555,472
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,789,057
Patent Claim Types: see list of patent claims	Use; Formulation; Dosage form;

Drugs Protected by US Patent 9,789,057

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Padagis Us	CLINDESSE	clindamycin phosphate	CREAM;VAGINAL	050793-001	Nov 30, 2004		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			METHOD OF TREATING BACTERIAL VAGINOSIS	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,789,057

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	047108	⤷ Start Trial
Argentina	058897	⤷ Start Trial
Australia	2004274000	⤷ Start Trial
Australia	2006332519	⤷ Start Trial
Brazil	PI0414500	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.